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ABSTRACT: Transcription factor NF-E2 p45-related factor 2
(Nrf2) and its principal negative regulator, Kelch-like ECH-
associated protein 1 (Keap1), comprise a molecular eﬀector and
sensor system that robustly responds to perturbations of the
cellular redox homeostasis by orchestrating a comprehensive
cytoprotective program. Under homeostatic conditions, Nrf2 is a
short-lived protein, which is targeted for ubiquitination and
proteasomal degradation. Upon encounter of electrophiles,
oxidants, or pro-inﬂammatory stimuli, the cysteine sensors in
Keap1 are chemically modiﬁed, rendering Keap1 unable to target
Nrf2 for degradation, and consequently leading to accumulation of
the transcription factor and enhanced transcription of cytopro-
tective genes. A detailed understanding of the protein−protein
interactions between Nrf2 and Keap1 has been achieved by use of
various in vitro systems, but few assays are available to assess these interactions in the context of the living cell. We previously
developed an imaging-based FLIM/FRET methodology to visualize and measure the interaction between Nrf2 and Keap1 in
single cells. Here, our goal was to improve this methodology in order to increase throughput and precision, and decrease cell-to-
cell variability. To eliminate the possibility of orientation bias, we incorporated a ﬂexible linker between Keap1 and the FRET
acceptor ﬂuorescent protein tag. To ensure the correct image capture of Nrf2 fused to the FRET donor ﬂuorescent protein tag,
we matched the maturation time of the ﬂuorescent tag to the half-life of the endogenous Nrf2, by using sfGFP as the FRET
donor. Using a global binning approach increased the assay throughput, whereas including the measured instrument response
function in the analysis improved precision. The application of this methodology revealed a strong covariation of the results
with the expression level of the acceptor. Taking the acceptor level into account circumvented cell-to-cell variability and
enhanced sensitivity of the measurements of the Keap1−Nrf2 interaction in live cells.
■ INTRODUCTION
Transcription factor NF-E2 p45-related factor 2 (Nrf2, gene
name NFE2L2) regulates the expression of a large network of
genes encoding inducible cytoprotective proteins that allow
mammalian cells and organisms to adapt and survive under
various conditions of stress.1 Together with its principal negative
regulator, Kelch-like ECH-associated protein 1 (Keap1), Nrf2
forms a molecular eﬀector and sensor system that robustly
responds to perturbations of the cellular redox balance and
orchestrates a comprehensive defense program, which in turn
restores homeostasis.2 The Nrf2 status aﬀects the production of
reactive oxygen species (ROS) by the two major ROS-
producing systems, mitochondria and NADPH oxidase.3
Among the Nrf2 transcriptional targets are proteins with critical
roles in the generation and utilization of reducing equivalents
such as NADPH and reduced glutathione (GSH), as well as
thioredoxin, thioredoxin reductase, peroxiredoxin, and sulﬁr-
edoxin, which collectively provide compartmentalized redox
sensing of ROS to maintain redox balance under homeostatic
conditions.4−6 By regulating NAD(P)H:quinone oxidoreduc-
tase 1 (NQO1), Nrf2 prevents quinones (which are generated
during metabolism of endogenous compounds, such as
estrogens and dopamine, as well as from dietary and environ-
mental sources) from participating in redox cycling reactions
and glutathione depletion.7 By regulating heme oxygenase 1
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(HMOX1) and biliverdin reductase, Nrf2 contributes to the
synthesis of bilirubin, the most potent nonpolar physiological
antioxidant.8
In addition to redox, Nrf2 has a role in intermediary
metabolism, including the metabolism of nucleotides,9 amino
acids,10 and lipids,11,12 and in providing substrates for
mitochondrial respiration.13 The importance of Nrf2 in
immunometabolism is also emerging, and it is becoming
increasingly recognized that Nrf2, which is activated during
metabolic reprogramming in activated macrophages, is critical
for resolution of inﬂammation,14−16 and that the sensing ability
and ﬂexibility of the cysteine sensors in Keap1 are essential for
the anti-inﬂammatory eﬀects of Nrf2 activators.17 It is therefore
not surprising that disturbances in the functions of Nrf2 and/or
Keap1 have been implicated in the initiation and progression of
most chronic diseases and aging. The Keap1/Nrf2 system is now
considered to be a drug target, with a substantial investment by
the pharmaceutical industry in the clinical development of Nrf2
modulators.18
Key to the regulation of Nrf2 is its interaction with Keap1,
which, in addition to serving as a cysteine-based sensor for
electrophiles and oxidants,19,20 is also a substrate adaptor for a
Cullin 3-based E3 ubiquitin ligase that continuously targets Nrf2
for ubiquitination and proteasomal degradation.21−23 Keap1 is a
homodimeric protein that binds to the Neh2 domain of
monomeric Nrf2 at two motifs: one with low aﬃnity (29-
DLG-31) and another with high aﬃnity (79-ETGE-82) (Figure
1A). Both motifs are required for ubiquitination, and the seven
lysine residues of Nrf2 that act as ubiquitin acceptors are
positioned between these motifs.24−26 Under unstressed
conditions, Nrf2 has a short half-life of about 15−40 min.27,28
During electrophilic, oxidative, or inﬂammatory stress, the
cysteine sensors in Keap1 are chemically modiﬁed.29−31
Consequently, Keap1 is unable to target Nrf2 for degradation,
thereby leading to rapid nuclear accumulation of Nrf2,
Figure 1.Measuring the Nrf2−Keap1 interaction with FLIM-FRET. (A) An interaction between Nrf2 N-terminally tagged with EGFP and Keap1 C-
terminally tagged with mCherry elicits FRET. EGFP is directly adjacent to the Neh2 domain of Nrf2 that contains two unequal binding sites for
Keap1the low aﬃnity DLG motif and the high aﬃnity ETGE motif (rectangles), at the indicated positions. Each of the sites interacts with the C-
terminal Kelch domain (blue circle) of dimeric Keap1, which positions mCherry next to EGFP and mediates FRET. Please note that Nrf2 and Keap1
are not drawn to scale. (B) Live HEK293 cells cotransfected with EGFP−Nrf2 and either free mCherry (top) or Keap1−mCherry (bottom) were ﬁrst
imaged to detect EGFP (green in overlay) and mCherry (red in overlay) ﬂuorescence (left panels). The ﬂuorescence lifetime (tm) of EGFP was
determined in the same cells by one-exponential decay ﬁtting of the photon arriving times, measured in each pixel using FLIM (middle panels,
spectrally color-coded between 1930 and 2300 as indicated). FRET eﬃciency calculated as in formula D from the same data (right panels) is spectrally
color-coded between 0 and 20%. To determine FRET eﬃciency, the ﬂuorescence lifetime of EGFP in the absence of acceptor (t2) was ﬁxed at 2275 ps,
and the ﬂuorescence lifetime in the presence of acceptor (tm) calculated from ﬁtting the two-exponential decay model as in formula C. (C) The mean
(dots) and standard deviation (error bars) of ﬂuorescence lifetime within the same nuclear area (left, top cell in B) or the same cytoplasmic area (right,
bottom cell in B) determined by ﬁtting a one-exponential decay model to the data with increasing level of binning. Global binning combines the entire
nucleus (left) or the entire cytoplasm (right) into one data set and thus produces a single tm value. (D) Mean tm values determined in a region that
outlines the entire nucleus or the entire cytoplasm analyzed with bin 4 correlate well with single tm values determined in the same region analyzed using
global binning. One-exponential decay ﬁtting was applied to all. Each dot corresponds to the nucleus or the cytoplasm of individual cells measured in
cells transfected with EGFP−Nrf2 with or without mCherry or Keap1−mCherry (to cover the entire range of values), and the line represents a linear
regression ﬁtted to the data, with Pearson correlation coeﬃcient (Pearson’s r) and R2 shown.
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dimerization with a small musculoaponeurotic ﬁbrosarcoma
(sMAF) protein, and activation of Nrf2-target gene tran-
scription. We previously established an imaging-based method-
ology to visualize and measure the interaction between Nrf2 and
Keap1 in single live cells and the eﬀect of small molecule
inducers on this interaction.32 The aim of the research described
in this contribution was to improve the existing methodology in
order to increase its throughput and precision.
■ EXPERIMENTAL PROCEDURES
DNA Constructs. Mouse Keap1 in pmCherry-N1 (Keap1−
mCherry), mouse Nrf2 in pEGFP-C1 (EGFP−Nrf2), EGFP in
mCherry-C1 (EGFP−mCherry), mouse Nrf2 lacking DLG motif in
pEGFP-C1 (EGFP-ΔDLG−Nrf2), and mouse Nrf2 with DLG motif
replaced by ETGE motif in pEGFP-C1 (EGFP-2xETGE−Nrf2), as
well as pEGFP-C1 and pmCherry-N1 (both from Clontech) were
previously described.32 sfGFP-C1 was purchased from Addgene
(N54579). The Keap1−6ﬂ-mCherry construct was generated by
PCR mutagenesis of the above Keap1−mCherry plasmid using the
Quick-Change II site-directed mutagenesis kit (Agilent technologies)
and primers ctgtacctgcCGATCGagtactGGATCCATGG-
TGAGCAAGGGCG and CGCCCTTGCTCACCATGGATCC-
agtactCGATCGgcaggtacag (Euroﬁns) designed to replace the linker
between Keap1 and mCherry by CGATCGagtactGGATCC sequence
that codes for a six amino-acid-long ﬂexible RSSTGS linker and
introduces unique PvuI, ScaI, and BamHI restriction sites. Mutagenized
plasmids were treated with DpnI to remove the old template and
introduced into chemicompetent DH10B bacteria that were
propagated on LB plates and in LBmedia in the presence of kanamycin.
DNA was isolated using Qiaprep spin miniprep kit (Qiagen). The
mutagenesis was conﬁrmed by a diagnostic digest (i.e., the plasmid was
linearized with BamHI) followed by sequencing. The Keap1−9ﬂ−
mCherry, Keap1−12ﬂ−mCherry, and Keap1−16ﬂ−mCherry con-
structs were generated by inserting a linker sequence encoded by an
annealed pair of the corresponding primers (Euroﬁn) shown in Table 1
into the PvuI and BamHI sites of the above Keap1−6ﬂ−mCherry
construct. The chemicompetent DH10B bacteria transformed by the
produced constructs were plated on kanamycin containing LB plates,
and colonies were screened for the loss of ScaI restriction site that
indicated a successful linker replacement that was further conﬁrmed by
sequencing. Mouse Nrf2 in sfGFP-C1 (sfGFP−Nrf2), mouse Nrf2
lacking the DLGmotif in sfGFP-C1 (sfGFP-ΔDLG−Nrf2), and mouse
Nrf2 with the DLG motif replaced by a second ETGE motif in sfGFP-
C1 (sfGFP-2xETGE−Nrf2) were generated by replacing the EGFP
sequence between AgeI and BsrGI restriction sites in EGFP−Nrf2,
EGFP-ΔDLG−Nrf2, and EGFP-2xETGE−Nrf2 constructs with the
corresponding sfGFP sequence obtained from AgeI/BsrGI-mediated
restriction digest of sfGFP-C1.
Cells and Treatments. HeLa and HEK293 cells were cultured in
DMEM medium supplemented with 10% heat-inactivated fetal bovine
serum (FBS). For immunoblots, 4× 105 cells were plated into each well
of a six-well plate 1 day before DNA transfection using lipofectamine
2000 (Invitrogen) and harvested at least 24 h after transfection. For
microscopy, 2 × 105 cells were seeded onto glass-bottom 3.5 cm cell
culture dishes (FluoroDish, World Precision Instruments) 1 day before
DNA transfection using the calcium phosphate method, in phenol-free
DMEM supplemented with 10% heat-inactivated FBS, and imaged the
day after transfection.
Immunoblotting.Cells were washed twice in PBS and lysed in SDS
lysis buﬀer containing 2% SDS, 62.5 mM Tris-HCl (pH 6.8), 10%
glycerol, and cOmplete Mini EDTA-free protease inhibitors (Roche
Diagnostics); boiled for 3 min; sonicated using a Sonics Vibra-Cell
Ultrasonic processor to shear DNA; and supplemented with DTT (up
to 0.1 M) and bromophenol blue. Cell lysate proteins (10 μg) and the
PageRuler prestained protein ladder (ThermoFisher Scientiﬁc, 26616)
were resolved on precast Bis-Tris 4−12% polyacrylamide gel
(ThermoFisher Scientiﬁc) under a MOPS running buﬀer and
transferred onto a Protran 0.45 μm nitrocellulose blotting membrane
(GE Healthcare Life Sciences) in transfer buﬀer containing 192 mM
glycine, 25 mM Tris, and 20% methanol. The membrane was stained
with 0.1% Ponceau S in 0.5% acetic acid, destained in 0.5% acetic acid,
and scanned using a BioRad ChemiDoc MP Imaging system operated
with Image Lab software (BioRad). After rinsing with PBS (Oxoid
Phosphate Buﬀered Saline, Dulbecco A, ThermoFisher, BR0014G), the
membrane was blocked for 1 h in blocking solution containing 5%
nonfat milk in PBS with 0.1% Tween 20. The blocked membrane was
incubated either overnight at 4 °C or for 1−4 h at room temperature
with the appropriate primary antibodies that had been diluted in
blocking solution. The membrane was washed three times in PBS with
0.1% Tween 20 and incubated for 1 h with the appropriate IRDye-
680RD or IRDye-800CW labeled anti-rabbit or anti-mouse secondary
antibody (LiCOR), diluted 1:15000 in blocking solution. After three
washes in PBS with 0.1% Tween 20, the membrane was scanned using
the Odyssey CLx Imaging System (LiCOR). The following primary
antibodies were used: rabbit anti−Nrf2 (Cell Signaling Technologies,
D1Z9C, 12721P, 1:1000 dilution), rabbit polyclonal anti-EGFP
(Abcam, ab6556, 1:1000 dilution) that detects both EGFP and
sfGFP, rabbit polyclonal anti-Keap1 [a kind gift from John Hayes
(University of Dundee), 1:2000 dilution],26 and mouse monoclonal
anti-β-actin (Sigma, clone AC-15, A 5441, clone AC-15, 1:20 000
dilution).
Live Cell Imaging. Cells were imaged using a confocal Zeiss LSM
710 microscope, operated with ZEN software (Zeiss), equipped with a
dark environmental chamber that maintains the temperature at 37 °C
and with a supply of humidiﬁed 5% CO2 to the cells. Cells were imaged
with 488 and 594 nm confocal lasers for EGFP/sfGFP and mCherry,
respectively, with a 63×/1.4NA oil immersion objective, immediately
prior to ﬂuorescence lifetime imaging (FLIM) of the same ﬁeld of view
(see below). The acquisition settings for confocal imaging were kept
consistent throughout the study, with low power/gain to avoid
saturation of bright areas and high averaging to increase signal-to-
noise ratio within dim areas.
FLIMMeasurements.The time-domain FLIMwasmeasured using
a SPC-150 Time-Correlated Single Photon Counter (TCSPC) module
(Becker &Hickl) operated with SPCM software (Becker &Hickl). The
two-photon laser (Coherent Chameleon) integrated with a Zeiss 710
microscope and operated with ZEN software generated the required
pulsed illumination with a repetition rate of 80MHz and pulse width of
140 fs. For EGFP and sfGFP excitation, the wavelength was set to 920
nm, and the emitted light was directed through 690 SP and 525± 25 BP
ﬁlters to the HPM-100-40GaAsP detector connected to the TCSPC
module. The data were collected with laser power adjusted to 0.8 × 105
− 8 × 105 events per second as detected by the Constant Fraction
Discriminator (CFD) within TCSPC, for 2 min, with a spatial
resolution of 512 × 512 pixels and a time resolution of 256 time
channels per curve. The output.sdt ﬁles were imported into SPCImage
software (Becker & Hickl) for analysis.
Table 1. Primers Used to Generate Extended Flexible Linkers between Keap1 and mCherry
linker sequence (peptide) primer sequence (DNA)
9ﬂ RSGKSGEGS 1 CGGGGaaaAGCGGCgaaG
2 GATCCttcGCCGCTtttCCCCGAT
12ﬂ RSGKSGSAGEGS 1 CGGGGaaaAGCGGCAGtGcTGGCgaaG
2 GATCCttcGCCAgCaCTGCCGCTtttCCCCGAT
16ﬂ RSGKSTGSEGSAGEGS 1 CGGGGaaaAGCactGGTTCAGAAGGCAGtGcTGGCgaaG
2 GATCCttcGCCAgCaCTGCCTTCTGAACCagtGCTtttCCCCGAT
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Image Analysis. The images of EGFP, sfGFP, or mCherry
ﬂuorescence generated in ZEN software were stored and processed
in OMERO.33 The mean ﬂuorescence intensities within outlined
nuclear or cytoplasmic regions of cells were determined using the ROI
tool in OMERO.insight. The mean intensity of the background
measured in several regions that did not contain cells was further
subtracted from the ﬂuorescence intensity data.
The ﬂuorescence lifetime analysis was performed in the SPCImage
software (version 5 or 6, see Figure S1), within the region of interest
(normally outlining either the nucleus or the cytoplasm of the imaged
cell), using an indicated level of spatial binning (n) that pools the data
from (2n + 1) × (2n + 1) adjacent pixels into a single data set, or using
global binning (see Figure S2A) that pools the data from the entire
region of interest into one data set. Fluorescence lifetime(s) in such
data sets is(are) determined by computational ﬁtting of the multi-
exponential decay model:
= τ−F t a( ) e for one component decayt/ (A1)
= +τ τ− −F t a a( ) e e for two component decayt t1 / 2 /1 2 (A2)
= + +τ τ τ− − −F t a a a( ) e e e for three component decayt t t1 / 2 / 3 /1 2 3
(A3)
where τ1, τ2, and τ3 are the ﬂuorescence lifetimes and a1, a2, and a3 are
the amplitude coeﬃcients of the individual components contributing to
the total decay function F(t).
Alternatively, in cases when the ﬂuorescence decay is too slow to be
completed within a single pulse period, the incomplete decay model
that includes the contribution from the previous excitation pulse is
used:
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whereM andT are the number and the length of the previous excitation
cycles as described in the SPCImage 5.0 manual (2015).
For single-component analysis, the obtained ﬂuorescence lifetime
value is
τ=tm
while two-component analysis generates two contributing ﬂuorescence
lifetimes t1 = τ1 and t2 = τ2, the relative amplitudes a1 and a2, as well as
the average lifetime tm = τm:
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The ﬁtting algorithm is in-built in SPCImage and incorporates
multiple user-deﬁned parameters, including the choice of themodel and
the number of components in the model. As part of the analytical
routine, the instrument response function (IRF, the signal generated by
the instrument itself) is removed from the primary data by
deconvolution. IRF was either estimated automatically within
SPCImage software (the detailed algorithm is provided in the sixth
edition of the bh TCSPC Handbook by Wofgang Becker; Figure S2B)
or measured as described.34 Brieﬂy, the decay proﬁle of 10 nm gold
nanorods (Sigma 716820), which have a negligibly short luminescence
lifetime, was measured at 920 nm, and the photon trace curve generated
by global binning of these measurements was used as the IRF curve
(Figure S2C). The temporal shift between the used IRF curve and the
actual start of IRF (“shift”) in the measured region was ﬁxed at the value
that was either determined empirically (by accepting the most frequent
value ﬁtted by the software in individual pixels) or obtained from a data
set generated by the global binning of the entire region by ﬁtting. In the
analysis of globally binned areas, the “shift” was left unﬁxed. The same
was done with the oﬀset, except it was ﬁxed at zero if the incomplete
decay model was used. Scatter was either ﬁxed at zero or left unﬁxed
(for globally binned data). The data were analyzed with one or two
component decay models as indicated. The goodness of ﬁt displayed by
the SPCImage software (Figures S1 and S2) was used to choose
between “standard” (A) or incomplete (B) decay models.
For measuring FRET eﬃciency, the two-component decay model
was used. In this simpliﬁed scenario, the total ﬂuorescence decay in each
measured region was regarded as a combination of the ﬂuorescence
decays of the unquenched donor molecules (with ﬂuorescence lifetime
unaﬀected by the FRET) and of the quenched donor molecules (with
ﬂuorescence lifetime reduced by FRET to a single discrete value due to
the proximity of the acceptor). On the basis of these assumptions, we
ﬁxed the t2 value (the larger of the two ﬂuorescence lifetime
components) to the value of ﬂuorescence lifetime of the donor in the
absence of acceptor and determined t1 (ﬂuorescence lifetime of
quenched donor) and the relative amplitudes a1 and a2 via the two-
component decay ﬁtting (eq A2). Average ﬂuorescence lifetime tm
derived as in eq C was then used within SPCImage to calculate FRET
eﬃciency using the formula
= −E tm t1 / 2FRET (D)
The above ﬁxed t2 value was obtained separately from measuring the
ﬂuorescence lifetime in cells overexpressing EGFP−Nrf2 or sfGFP−
Nrf2 without an acceptor.
Numerical data from ﬂuorescence intensities and ﬂuorescence
lifetime measurements were compiled in Excel spreadsheets and
analyzed in R or in Excel. Scatterplots and the linear regression ﬁtting
were made in R.
Statistical Analysis.Mean and standard deviations were calculated
either in Excel or in R. For correlation analysis, the Pearson’s correlation
coeﬃcient, p values for Pearson correlation, the R2, and the slope of the
ﬁtted linear regression functions were obtained in R. For comparison
between groups, p values were determined using a Wilcoxon rank sum
test or Welch two sample t test in R.
■ RESULTS AND DISCUSSION
Limitations of the Existing Methodology for Monitor-
ing the Nrf2−Keap1 Interaction in Single Live Cells. The
binding between ectopically coexpressed Nrf2 and Keap1
proteins fused to EGFP and mCherry, respectively, at the sites
proximal to their interaction interface (the N-terminus of Nrf2
and the C-terminus of Keap1) induces a nonradiative energy
transfer, termed Förster Resonance Energy Transfer (FRET),
between the EGFP andmCherry ﬂuorophores (Figure 1A). This
in turn causes a reduction in the ﬂuorescence lifetime, the time
between excitation and emission, of the FRET donor, EGFP.
The FRET eﬃciency (EFRET) calculated as the relative loss of
donor ﬂuorescence lifetime in the presence of acceptor (eq 1)
provides a measure of the interaction:
= −E t t1 (DA)/ (D)FRET (1)
where t(DA) is the donor ﬂuorescence lifetime in the presence
of an acceptor and t(D) is the donor ﬂuorescence lifetime in the
absence of an acceptor.35
An example of such analysis is given in Figure 1B. Using time-
domain Fluorescence Lifetime Imaging Microscopy (FLIM),
the ﬂuorescence lifetimes (middle panels) and their correspond-
ing FRET eﬃciencies (right panels) are determined in each pixel
of the image of cells cotransfected with EGFP-labeled Nrf2 and
either mCherry-labeled Keap1 (bottom panels) or free mCherry
(top panels), which was used as a negative control. The
interaction between Keap1 and Nrf2 is apparent from the
shorter ﬂuorescence lifetime (tm) of EGFP and the higher FRET
eﬃciency values in the presence of Keap1−mCherry, compared
to mCherry. Notably, Keap1−mCherry eﬃciently retains
EGFP−Nrf2 in the cytoplasm, whereas in the absence of
Keap1−mCherry, the overexpressed EGFP−Nrf2 is nuclear
(Figure 1B, left panels). Using this method, it is possible to
examine the steady-state level of the Keap1−Nrf2 interaction in
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diﬀerent cellular regions and observe how Nrf2 inducers change
this interaction in real time.32,36,37 However, high cell-to-cell
variability, combined with the extremely low throughput of both
measurement and analysis, represent major limitations. There-
fore, we set out to improve the current methodology.
Increasing Throughput by Global Binning. First, we
made adjustments to the analytical routine with the aim to both
simplify it and increase its accuracy. In time-domain FLIM, the
ﬂuorescence lifetime value, tm, in a given pixel of an image is
obtained by a computational ﬁtting of the exponential decay
model to a data set that contains experimentally measured times
of photon emission, relative to the time of excitation (Figure S1
and Image Analysis within Experimental Procedures). The
accuracy of ﬁtting strongly depends on the number of detected
photons that accumulate over multiple pulses of laser
illumination. Whereas the number of photons could be
increased theoretically by extending the duration of acquisition
or by increasing the power of the laser, the live cell imaging
imposes strict limitations on both of these parameters, due to
cell movement and phototoxicity. It is, however, possible to
increase the size of the data set by combining the data from
several adjacent pixels into one set, a process termed binning, at
the expense of spatial resolution. This approach reduced the
uncertainty in the ﬁtted tm values, as evidenced by the decrease
in the standard deviation of the tm value among pixels, and
removed the bias that lowers the mean tm values when the
photon number is insuﬃcient (Figure 1C). An extreme case of
binning, referred to further as “global binning,” combines all data
of the entire cellular region of interest into one data set (Figures
1C and S2A). We have previously observed relatively
homogenous EGFP-Nrf2 ﬂuorescence lifetimes within either
the nucleus or the cytoplasm, and thus do not anticipate an
increase in the complexity of the samples upon binning of the
entire nuclear or cytoplasmic area into a single data set. Notably,
the high number of photons obtained using this approach allows
conﬁdent ﬁtting of the multiexponential decay function even in
dim areas of the image (Figure S2). The increased analytical
power is suﬃcient to computationally ﬁt additional parameters
that are otherwise manually (and somewhat arbitrarily) ﬁxed by
the user, such as temporal shift of the signal generated by the
instrument (the instrument response function, IRF) relative to
the start of the data curve, the oﬀset, and the scatter, all of which
increase the precision of the analysis. Furthermore, the global
binning approach oﬀers a one-step, virtually instantaneous
analysis that greatly increases the throughput. Importantly, we
conﬁrmed a strong correlation between tm obtained from the
analysis of globally binned data and mean tm from pixel-by-pixel
analysis of the same areas of the cells (Figure 1D). Thus, whereas
globally binned data are unable to report on the variability within
the measured region of interest, they provide a useful measure
that represents such regions in studies that address cell-to-cell
variability.
Improving Precision by Use of Measured Instrument
Response Function. The precision of the measurements was
further improved by using the measured IRF in the analysis of
FLIM data. The IRF signal is separated and removed from the
decay data by deconvolution prior to data analysis within the
FLIM analysis software. The SPCImage software allows the
generation of a synthetic IRF proﬁle from the shape of the rising
edge of the ﬂuorescence signal, and we previously used such
estimated IRF in our analysis32 (Figure S2B). Here, we
determined and used the real shape of the IRF curve by
measuring the decay proﬁle of ultrafast luminescence of gold
nanorods at the wavelength used for EGFP acquisition34 (Figure
Figure 2. Analysis of the Keap1−Nrf2 interaction using global binning. HEK293 cells were transfected with plasmids encoding wild-type EGFP−Nrf2
or the EGFP−Nrf2 mutant with either lower (ΔDLG) or higher (2xETGE) aﬃnity for Keap1, either alone or together with mCherry or Keap1−
mCherry, and subjected to FLIM. The EGFP ﬂuorescence lifetime (tm) was analyzed in the cytoplasmic and nuclear areas of the imaged cells, by ﬁtting
an incomplete one-exponential decay model to data sets generated by global binning of the data from such areas. Each dot represents the tm value in
either the nucleus or the cytoplasm of an individual cell; 7−16 cells were measured for each type of transfection. The box plots show the distribution of
values within each group of identically transfected cells: the box outlines the range between the 25th and 75th percentiles, the thick line within the box
marks the median, and the whiskers show minimum and maximum values that extend from the box by no more than 1.5 times interquartile range (the
distance between the 25th and 75th percentiles). The p values for signiﬁcant (black) and highly signiﬁcant (red) diﬀerence in tm between groups are
shown. Note that lower tm indicates a stronger Nrf2−Keap1 interaction.
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S2C). This signiﬁcantly increased the goodness of ﬁt in our
analysis (note the decrease in χ2 in Figure S2C compared to
Figure S2B).
Using theOptimized Parameters to Analyze theNrf2−
Keap1 Interaction. The global binning approach was applied
to analyze the Nrf2−Keap1 interaction in the entire cytoplasm
or the entire nucleus. For simplicity, we used a single-
exponential ﬁtting, however the two-exponential decay analysis
showed a very similar trend, regardless of whether the complete
or incomplete decay model was used (Figure S3). This analysis
revealed a robust reduction in tm in cells coexpressing EGFP−
Nrf2 and Keap1−mCherry in comparison with cells expressing
either EGFP−Nrf2 alone or coexpressing EGFP−Nrf2 and free
mCherry, indicative of FRET due to the Nrf2−Keap1
interaction (Figure 2). This conﬁrmed our previous results for
the cytoplasm32 and further revealed the occurrence of a similar
interaction in the nucleus. Moreover, the reduction in tm was
signiﬁcantly smaller in cells coexpressing Keap1−mCherry and
the EGFP−Nrf2 mutant that lacks the weak Keap1-binding
motif DLG (ΔDLG−Nrf2), indicating a weaker interaction, in
agreement with the reduced aﬃnity of this Nrf2 mutant for
Keap1.24 Conversely, the reduction in tm was greater in cells
coexpressing Keap1−mCherry and the EGFP−Nrf2 mutant, in
which the DLG motif was replaced with the strong Keap1-
binding motif ETGE (2xETGE−Nrf2), indicating a stronger
interaction. Notably, the interactions between the fusion
proteins showed a similar pattern in both the cytoplasm and
the nucleus.
Optimizing the Linker between Keap1 and mCherry.
To further increase the sensitivity of the assay and to rule out
potential orientation bias in our system, we next optimized the
linker between Keap1 and mCherry. Since FRET is sensitive to
the mutual orientation of the ﬂuorophores,38 the changes in
conformation of the protein complex that aﬀect ﬂuorophore
orientation could alter FRET eﬃciency and complicate its
interpretation. For intermolecular FRET to report primarily on
the interaction strength (i.e., distance between partners and/or
frequency of interaction), the ﬂexible linkers39 between proteins
and their ﬂuorescent tags are preferable. The existing linker
between Keap1 and mCherry, AEAAAKEAAAKAPVAT
(Figure 3A, top), forms a rigid two-turn helix that may introduce
an unwanted bias toward a particular geometrical conﬁguration
of the complex. We ﬁrst replaced the rigid linker with a short six-
amino acid ﬂexible linker that incorporated three restriction sites
for the ease of further mutagenesis (Figure 3A, second construct
from top). We then generated a series of Keap1−mCherry
constructs with ﬂexible linkers of increasing length (Figure 3A).
While the Keap1−mCherry construct with a six-amino-acid
ﬂexible linker shortened the ﬂuorescence lifetime of EGFP−
Nrf2 to a similar extent as the original Keap1−mCherry
construct, a further increase in the linker length, up to 12 amino
acids, gradually enhanced its FRET capacity, which decreased
again when the size of the ﬂexible linker was extended to 16
amino acids (Figure 3B). Analysis of the interaction between
both ΔDLG and 2xETGE EGFP−Nrf2 mutants and the
Keap1−mCherry constructs containing ﬂexible linkers of
diﬀerent sizes revealed that all of them were able to discriminate
between those mutants of Nrf2 (Figure 3C and D), conﬁrming
that the diﬀerence in FRET eﬃciency between Nrf2 mutants is
not due to an orientation bias of the original Keap1−mCherry
construct.
Since the construct with the 12 amino acid ﬂexible linker was
the most eﬃcient in mediating FRET, we used this Keap1−
mCherry construct (designated Keap1−12ﬂ−mChe) in our
subsequent experiments. The sensitivity of this construct
combined with the above analytical routine was further tested
on samples that coexpressed high-aﬃnity and low-aﬃnity
EGFP-labeled Nrf2 mutants at diﬀerent ratios (Figure S4).
The Keap1−Nrf2 interaction was signiﬁcantly weaker in cells
expressing a mixture ofΔDLG−Nrf2 and 2xETGE−Nrf2 at 1:2
Figure 3.Optimization of the linker between Keap1 and mCherry. (A) Cloning strategy. The top drawing depicts the existing construct with the rigid
linker (blue) between the Keap1 (gray rectangle) and themCherry tag (red rectangle). The construct underneath is cloned by replacing the linker with
a short, six-amino-acid ﬂexible linker (green); its DNA sequence incorporated three unique restriction sites. PvuI and BamHI sites were further used to
facilitate replacement of this linker by ﬂexible linkers of an increasing length (9-, 12-, or 16-amino-acid-long, bottom three schematics), while the ScaI
served as a site for diagnostic digest to detect such a replacement, as it was absent in any further linker sequence. The amino acid sequences of the
corresponding linkers are shown on the right. (B) HEK293 cells transfected with EGFP−Nrf2 alone or in the presence of one of the Keap1−mCherry
constructs outlined in A. The EGFP ﬂuorescence lifetime (tm) was measured, analyzed, and represented as in Figure 2 in the nuclear and cytoplasmic
areas of 7−19 cells per group. In addition, cells transfected with EGFP−mCherry construct serving as the “maximal FRET” control were included in
themeasurements. (C andD) Live FLIM analysis of HEK293 cells transfected withΔDLG (dD) and 2xETGE (2E)Nrf2mutants fused to EGFP, with
or without the Keap1−mCherry constructs shown in A. The EGFP ﬂuorescence lifetime (tm) was measured, analyzed, and represented as in Figure 2
in the cytoplasmic (C) or the nuclear (D) areas.
Chemical Research in Toxicology Article
DOI: 10.1021/acs.chemrestox.8b00354
Chem. Res. Toxicol. 2019, 32, 500−512
506
ratio compared to those expressing 2xETGE−Nrf2 alone, and
this was further reduced at a ΔDLG−Nrf2 and 2xETGE−Nrf2
ratio of 2:1. This observation demonstrates that the method is
suitable for the detection of subtle changes in the ability of Nrf2
to bind Keap1 even in samples with complex composition.
Matching the Maturation Time of the Fluorescent
Protein Tag to the Half-Life of Nrf2.One of the obstacles in
using the existing method was fast degradation of FRET-donor-
labeled Nrf2, particularly in the presence of Keap1. Nrf2 is a very
short-lived protein, with a half-life of about 15−40 min,
depending on the cell line.27,28 Since the maturation time of
Figure 4. Assessment of the sfGFP tag. (A) sfGFP−Nrf2 and EGFP−Nrf2 have similar expression levels and the ability to be degraded by Keap1−
mCherry. HEK293 cells transfected for 1 day with either sfGFP- or EGFP-tagged Nrf2, either alone or together with Keap1−mCherry, were lysed and
immunoblotted for Nrf2, GFP, and actin (as a loading control). (B) The cellular localization of sfGFP−Nrf2 and EGFP−Nrf2 is identical. HEK293
transfected with Nrf2 tagged with either EGFP (left) or sfGFP (right), with (bottom) or without (top) Keap1−12ﬂ−mCherry were imaged using
confocal microscopy to detect EGFP/sfGFP that have identical ﬂuorescence spectra (green in overlay) or mCherry (red in overlay). Note that the
nuclear localization of both tagged versions of Nrf2 is changed to predominantly cytoplasmic when Keap1−mCherry is coexpressed. (C) The
ﬂuorescence lifetime (tm) of sfGFP and EGFP was measured in live HEK293 cells transfected with the corresponding construct. The data were
analyzed and are represented as in Figure 2. Note that the tm of sfGFP is slightly lower and noisier than that of EGFP.
Figure 5. sfGFP is a good FRET donor for the FLIM−FRET Nrf2−Keap1 interaction assay. HEK293 cells were transfected with wild-type sfGFP−
Nrf2 or sfGFP−Nrf2 mutant with either lower (ΔDLG, dD) or higher (2xETGE, 2E) aﬃnity for Keap1, either alone or together with Keap1−12ﬂ−
mCherry, and subjected to FLIM. The sfGFP ﬂuorescence lifetime (tm) in the cytoplasmic and nuclear areas of the imaged cells was analyzed and
presented as in Figure 2.
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EGFP (the time from synthesis to the onset of ﬂuorescence) is
more than 30 min,40 a signiﬁcant proportion of EGFP−Nrf2 is
likely to degrade before it becomes detectable. Therefore, the
obtained data might not fully represent the bulk of Nrf2
behavior. In order to overcome this limitation, we replaced
EGFP in EGFP−Nrf2 with superfolder GFP (sfGFP),41 which
has ﬂuorescence spectra very similar to EGFP but a much faster
maturation time, 6−7 min.42 Coexpression with Keap1−
mCherry led to an identical decrease in the levels of ectopically
expressed sfGFP−Nrf2 as those of EGFP−Nrf2 (Figure 4A).
The localization of sfGFP−Nrf2 ectopically expressed in
HEK293 (Figure 4B) or HeLa cells (not shown) was
indistinguishable from that of EGFP−Nrf2, either in the
presence or in the absence of Keap1−mCherry. The
ﬂuorescence lifetime of sfGFP in cells was 2156 ± 25 ps in
cytoplasmic and 2148 ± 33 ps in nuclear regions (Figure 4C),
slightly shorter and more variable than that of EGFP. FRET
between sfGFP−Nrf2 and Keap1−12ﬂ−mCherry was detected
in both the cytoplasm and the nucleus (Figure 5), and in the
cytoplasm, there was a clear and signiﬁcant diﬀerence in the level
of Keap1 interaction between wild-type Nrf2 and ΔDLG or
2xETGE Nrf2 mutants labeled with sfGFP. Collectively, these
data strongly suggest that sfGFP−Nrf2 and EGFP−Nrf2
interact with Keap1−mCherry in the same manner. Further-
more, the ﬂuorescence intensity of the sfGFP−Nrf2 expressing
cells was greatly increased in comparison to EGFP−Nrf2
expressing cells, which increased both the speed of the
measurements and the representability of the data. Thus, the
sfGFP:mCherry ﬂuorophore pair oﬀers a valid alternative for
FRET measurements of short-lived proteins using FLIM.
Identifying the Level of Acceptor As a Contributing
Factor to Cell-to-Cell Variability. Another factor that
undermines the robustness of the existing assay is high cell-to-
cell variability. In order to determine the source of this
variability, we analyzed the relationship between the ﬂuo-
rescence intensity of the donor or acceptor and the ﬂuorescence
lifetime of the donor, within each group. For cells expressing the
sfGFP−Nrf2 donor alone, the ﬂuorescence intensity of sfGFP
moderately correlated with tm values (Figure 6A, left panel).
While the ﬂuorescence lifetime is considered to be independent
of the donor concentration,35 our data indicate that the donor
expression level aﬀects the tmmeasurements to some degree. In
order to limit the potential eﬀect of homo-FRET43 that might
occur at high ﬂuorophore density, and any artifacts induced by
phototoxicity, the brightest cells with extreme levels of
overexpressed protein were excluded from this analysis.
Figure 6. Contribution of GFP and mCherry intensities to the cell-to-cell variability in the GFP ﬂuorescence lifetime. (A) The sfGFP ﬂuorescence
lifetime (tm) determined using a one-exponential decay model with global binning in the nuclear or cytoplasmic regions of HEK293 cells expressing
sfGFP−Nrf2 (wild-type or mutants) was plotted against themean sfGFP intensity measured in the same regions of the cell. Fitting the linear regression
to the data conﬁrmed the correlation between tm and sfGFP ﬂuorescence level (Pearson’s coeﬃcient and adjustedR2 are shown on the plot, left panel).
On the basis of the slope of the linear regression line (slope =−0.6894), the tm for each data point was further corrected for the sfGFP intensity using
the formula: tm corrected = tm + [0.6894 × (sfGFP intensity− 50)]. The corrected tm values plotted against the sfGFP intensity for the same data set
(right panel) revealed complete correction, apparent from the lack of slope in the ﬁtted linear regression. (B) sfGFP ﬂuorescence lifetime measured in
the nuclear or cytoplasmic regions of HEK293 cells coexpressing sfGFP−Nrf2 and free mCherry corrected as in A (tm corrected) was plotted against
the mean ﬂuorescence level of mCherry. The Pearson’s coeﬃcient, the adjusted R2 value (shown on the plot), and the lack of slope of the ﬁtted linear
regression conﬁrm the lack of correlation between the plotted values. (C) Correlation between sfGFP ﬂuorescence lifetime in the nuclear or
cytoplasmic regions of HEK293 cells coexpressing sfGFP−Nrf2 and Keap1−12ﬂ−mCherry measured as in A and the logarithm of the mean mCherry
ﬂuorescence, without (left panel) and with (right panel) correction for sfGFP ﬂuorescence as in A, is apparent from the slope of the ﬁtted linear
regression and the corresponding Pearson’s coeﬃcient and adjusted R2 values as shown. (D) No correlation between the corrected tm and the ratio
between acceptor and donor in the sample coexpressing sfGFP−Nrf2 and Keap1−mCherry. Corrected tm values in the same data set as in C were
plotted against the ratio between mCherry and sfGFP ﬂuorescence intensities. Fitted linear regression, Pearson’s coeﬃcient, and adjusted R2 are
shown.
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Additionally, in order to prevent the bias toward shorter tm due
to exclusion of late arriving photons if more than one photon is
excited within the same pulse of the laser illumination, the so-
called pile-up eﬀect, the acquisition speed was set to maintain
the low count rate 0.8 × 105 − 8 × 105 events per second,
corresponding to 0.001−0.01 photons per pulse). However,
despite these precautions, the correlation between donor
ﬂuorescence lifetime and its total ﬂuorescence level always
remained. The same trend was seen with EGFP (Figure S5).
In order to remove the above eﬀect from further analysis, we
ﬁtted a linear regression function to the data shown in Figure 6A,
left panel, and determined the slope of the regression line. This
value was used to calculate the corrected tm that takes the total
sfGFP intensity into account (Figure 6A, right panel). We
further analyzed the eﬀect of free mCherry coexpressed with the
donor on the donor ﬂuorescence lifetime. After correction for
the level of sfGFP intensity, the sfGFP ﬂuorescence lifetime was
not dependent on mCherry ﬂuorescence over a large range of its
intensities (Figure 6B), and was only reduced at extremely high
levels of mCherry (Figure S6).
However, in cells that coexpressed sfGFP−Nrf2 and Keap1−
mCherry, the relationship between tm or corrected tm with
donor and acceptor intensities was more complex (Figure S7
and Table S1). The logarithm of the mean mCherry intensity
showed the strongest correlation with sfGFP ﬂuorescence
lifetime, based on the Pearson’s coeﬃcient and R2 values,
without (Figure 6C, left panel) or with (Figure 6C, right panel)
correction for the total sfGFP intensity. One possible
explanation for such correlation could be a suboptimal
concentration of acceptor in our system, which is dictated by
the need to maintain Keap1−mCherry at a relatively low level to
avoid degradation of sfGFP−Nrf2 beyond detectable levels
(Figure S8). FRET eﬃciency has been previously shown to be
low at the suboptimal concentration of FRET acceptor relative
to that of FRET donor, and to increase with the ratio between
the FRET acceptor and the FRET donor until it reaches a
plateau when the acceptor is in excess over the donor.44
Surprisingly, we found no correlation between the corrected
(Figure 6D) or uncorrected (Figure S7 and Table S1) sfGFP
ﬂuorescence lifetime (that is inversely related to FRET
eﬃciency, see formulas D and 1 and Figure 1B) and the ratio
Figure 7. Analysis of the donor ﬂuorescence lifetime in the context of the acceptor level reveals high reproducibility of Nrf2−Keap1 interaction
measurements. (A) The sfGFP ﬂuorescence lifetime (tm) of cytoplasmic (left) or nuclear (right) regions of HeLa cells cotransfected with sfGFP−Nrf2
and Keap1−12ﬂ−mCherry was measured and analyzed as in Figure 2 in three independent experiments acquired on diﬀerent days. (B) The same data
plotted against the logarithm of mean mCherry intensity measured in the same regions, with linear regressions ﬁtted independently to each
experimental data set. The data from experiments 1, 2, and 3 (shown in A) are color-coded as red, blue, and black, respectively. (C) HEK 293 cells
transfected with Keap1−12ﬂ−mCherry and either wild-type sfGFP−Nrf2 (black) or mutant sfGFP−Nrf2 in which the low-aﬃnity DLG site was
replaced by a second high-aﬃnity ETGE site (sfGFP−2xETGE−Nrf2, blue) were measured and analyzed as in Figure 6C. The corresponding linear
regressions were ﬁtted independently to each data set and are similarly color-coded. (D) The sfGFP ﬂuorescence lifetime (tm) of the cytoplasmic
(black) or nuclear (red) regions of HeLa cells cotransfected with sfGFP−Nrf2 and Keap1−12ﬂ−mCherry were measured and analyzed as in Figure
6C. Linear regression was ﬁtted to the entire data set.
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between acceptor and donor intensities in samples coexpressing
sfGFP−Nrf2 and Keap1−12ﬂ-mCherry. Thus, within the range
of ﬂuorescence intensities used in our measurements, the
absolute level of acceptor attached to the binding partner, rather
than the acceptor to donor ratio, is linked to the cell-to-cell
variability in the ﬂuorescence lifetime of the FRET donor. It is
possible that this unique behavior results from complex
multiway dependencies between the eﬃciency of interaction
and the expression levels of EGFP−Nrf2 and Keap1−mCherry.
While the precise reason for the above correlation remains to
be determined, we nevertheless decided to utilize it to increase
the robustness and sensitivity of the assay, by analyzing the
donor ﬂuorescence lifetime in the context of the acceptor level.
Such two-dimentional representation revealed a high level of
reproducibility of the measurements between experiments
(compare Figure 7B with 7A). It could clearly discriminate
between wild-type Nrf2 and the 2xETGE−Nrf2 mutant with
increased aﬃnity for Keap1 that showed a reduction in tm across
the entire range of acceptor intensity (Figure 7C), consistent
with higher FRET eﬃciency between the mutant Nrf2 protein
and Keap1−12ﬂ−mCherry. Furthermore, inspection of the
correlation between tm and logarithm of acceptor intensity in
diﬀerent cellular compartments revealed that it does not
signiﬁcantly diﬀer between nuclear and cytoplasmic areas
(Figure 7D). This observation suggests that the main cause of
the lower FRET eﬃciency in the nucleus compared to the
cytoplasm in our assay (Figures 2, 3B, 5, and 7A) is the low
abundance of acceptor, which in turn is caused by the
predominant cytoplasmic localization of Keap1 (see Figure
1B),45 and is not due to diﬀerences in the overall aﬃnity of Nrf2
for Keap1 between the two subcellular compartments.
■ CONCLUDING REMARKS
We have developed an improved imaging-based FLIM/FRET
methodology to monitor the interaction between Nrf2 and
Keap1 in single live cells, with strongly increased throughput
compared to the previously described method. The use of global
binning increases the throughput of the assay, and the use of the
measured instrument response function in the analysis improves
its precision. Incorporating a ﬂexible linker between Keap1 and
the FRET acceptor ﬂuorescent protein tag eliminates the
possibility of introducing an orientation bias. We showed that
sfGFP:mCherry ﬂuorophore combination is an appropriate
choice for measuring the FLIM−FRET of short-lived proteins
and that matching the maturation time of the donor with the
short half-life of Nrf2 improves capture of representative images
without any detectable drawbacks. Finally, we identiﬁed the level
of acceptor as the main factor that correlates with cell-to-cell
variability and, more importantly, developed the strategy to
eliminate its eﬀect from measurements of the Keap1−Nrf2
interaction.
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